You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIV-1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GeneXpert HIV-1 as The Gold Standard Test for HIV-1 Viral Load

Completed
  • HIV
    • Tangerang, West Java, Indonesia
      RSU Kabupaten Tangerang
    Jul 27, 2023

    HIV-1-infection Trial (Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir))

    Not yet recruiting
    • HIV-1-infection
    • Low-dose STP0404 (Pirmitegravir)
    • +3 more
    • (no location specified)
    May 16, 2023

    HIV-1 Reservoir During Cure Interventions Studies (MERCI)

    Not yet recruiting
    • Hiv
      • Ghent, Belgium
        Ghent University Hospital
      Mar 13, 2023

      HIV, HIV Pre-exposure Prophylaxis Trial (MK-8527, Placebo to MK-8527)

      Not yet recruiting
      • HIV
      • HIV Pre-exposure Prophylaxis
      • (no location specified)
      Sep 21, 2023

      Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction

      Not yet recruiting
      • Hiv
      • +5 more
      • differences in CD4 reconstruction
      • (no location specified)
      Sep 17, 2023

      Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases

      Not yet recruiting
      • Multi-Drug Resistant Hiv-1 Infection
      • HIV-1 Infection
      • UB-421
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      HIV-1-infection Trial (Delstrigo, KOCITAF)

      Not yet recruiting
      • HIV-1-infection
      • (no location specified)
      Jun 20, 2023

      HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)

      Active, not recruiting
      • HIV-1-infection
      • ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
      • Amsterdam, Noord-Holland, Netherlands
        Amsterdam University Medical Centers, location AMC
      Jan 31, 2023

      HIV-1, Human Immunodeficiency Virus 1, Immunodeficiency Virus Type 1, Human Trial (MK-8510)

      Not yet recruiting
      • HIV-1
      • +3 more
      • (no location specified)
      Jan 17, 2023

      Hiv Trial in United States (V3G CH848 Pr-NP1 60mcg, 3M-052-AF 5mcg, Alum 500 mcg)

      Not yet recruiting
      • Hiv
      • V3G CH848 Pr-NP1 60mcg
      • +5 more
      • Birmingham, Alabama
      • +5 more
      Jun 5, 2023

      HIV-1-infection Trial (B/F/TAF)

      Not yet recruiting
      • HIV-1-infection
      • (no location specified)
      Oct 23, 2023

      Healthy Trial (763SIP8/MPLA-5 vaccine)

      Not yet recruiting
      • Healthy
      • 763SIP8/MPLA-5 vaccine
      • (no location specified)
      Mar 15, 2023

      Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)

      Active, not recruiting
      • Hiv
      • HIV-1-infection
      • Lamivudine 300 MG
      • Emtricitabine / Tenofovir Disoproxil Pill
      • Buenos Aires, Argentina
        Fundacion IDEAA
      Jan 2, 2023

      Analysis of HIV-1 Replication During Antiretroviral Therapy

      Enrolling by invitation
      • HIV
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 13, 2023

        Syphilis, HIV Trial in Regina (Reveal Rapid TP (from MedMira))

        Recruiting
        • Syphilis
        • HIV Infections
        • Reveal Rapid TP (from MedMira)
        • Regina, Saskatchewan, Canada
        • +1 more
        May 8, 2023

        HIV-1 Infection Trial (DOR/ISL, BIC/FTC/TAF, Placebo to DOR/ISL)

        Not yet recruiting
        • HIV-1 Infection
        • (no location specified)
        Jan 20, 2023

        HIV Testing, HIV Trial in Edmonton, Toronto, Montréal (OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test)

        Active, not recruiting
        • HIV Testing
        • HIV Infections
        • OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test
        • Toronto, Ontario, Canada
        • +3 more
        Jan 24, 2023

        HIV Vaccine, HIV-1-infection Trial in Chapel Hill, Durham (C62, C1C62, Placebo)

        Recruiting
        • HIV Vaccine
        • HIV-1-infection
        • C62
        • +4 more
        • Chapel Hill, North Carolina
        • +1 more
        Oct 27, 2022

        Virologic Response in Participants Newly Diagnosed With HIV-1

        Completed
        • HIV
        • Antiretroviral Therapy
        • Lisboa, Portugal
          Chlo - Hosp. Egas Moniz
        Jan 17, 2023

        HIV-1-infection, Sexually Transmitted Diseases Trial in Madrid (Description)

        Completed
        • HIV-1-infection
        • Sexually Transmitted Diseases
        • Description
        • Madrid, Spain
          Hospital Universitario Infanta Leonor
        Aug 16, 2023

        Acceptability for HIV-1 and Hepatitis B (TINIES for BBVs)

        Not yet recruiting
        • HIV Infections
        • Hepatitis B
        • Doctors Laboratory TINIES small volume blood testing kit
        • (no location specified)
        Jan 10, 2023

        HIV Positive Trial in Saint-etienne (blood and urinary samples)

        Not yet recruiting
        • HIV Positive
        • blood and urinary samples
        • Saint-etienne, France
          Chu Saint-Etienne
        Nov 29, 2022

        Quantification of Antisense HIV RNA in Patients

        Recruiting
        • HIV-1-infection
        • Blood sampling
        • Paris, France
          Jean-Paul VIARD
        Dec 21, 2022

        HIV-1-infection Trial in Edmonton (B/F/TAF, Atripla, B/F/TAF Placebo)

        Terminated
        Has Results
        • HIV-1-infection
        • Edmonton, Alberta, Canada
          University of Alberta
        Nov 21, 2022

        HIV-1 Infection Trial (ART, DOR/ISL)

        Not yet recruiting
        • HIV-1 Infection
        • (no location specified)
        Jan 4, 2023